Goodwin partner Emily Townsend, from London, practices in the firm's Technology and Life Sciences groups. Learn more about Emily.

Emily Townsend

Partner
Emily Townsend
London
+44 (0)20 4536 3081

Emily Townsend is a partner in Goodwin’s Technology group in London. Emily advises clients on a broad range of matters throughout the corporate lifecycle, with a focus on venture capital and growth equity financings and M&A transactions.

Experience

  • Dwelly on its $170 million Series B financing
  • Flying Fish, Evantic, and BOND on their participation in the $1.1 billion investment round into Ineffable Intelligence
  • Oxford Quantum Circuits on its $350 million Series C financing and $100 million Series B financing
  • General Catalyst in the €150 million Series E financing of ICEYE
  • The Chernin Group in its strategic partnership with Goalhanger
  • General Catalyst, Bertelsmann, and Meridian Health Ventures on Phare Health’s acquisition by R1
  • Omnipresent on its acquisition by Deel
  • General Catalyst in the $67.5 million Series B financing of Lean Technologies
  • Paid on its $21.6 million seed round
  • Ravelin on its acquisition by Worldpay
  • ETF Partners on its investment in the $75 million Series C financing of Riverlane
  • Myricx on its £90 million Series A financing, co-led by Novo Holdings and Abingworth
  • Relay Technologies on its $35 million and $10 million financings
  • Anaphite on its £10.4 million funding round
  • VavaCars on its $37 million Series C financing*
  • Geopura on its £36 million Series A financing*
  • Dawn Capital on its investment into Elwood Technologies as part of a $70 million Series A financing*
  • Current Health on an acquisition by Best Buy for $400 million*
  • Trustology on its sale to Bitpanda*

*Denotes experience prior to joining Goodwin

Credentials

Education

Legal Practice Course2016

BPP Law School

LLB2015

University of Leicester

Admissions

Bars

  • England and Wales